The above results indicated that ajugol in RR has a more marked effect on the levels of proteins involved in the apoptosis pathway (downregulating the cytochrome C/caspase-3 ratio and upregulating the BCL-2/BAX protein ratio), which may underlie its anti-AD effects. The gene discussed is BCL2; the disease is Alzheimer disease.